Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement. But industry observers note that big pharma companies are also raising some prices overseas as part of a strategy to protect U.S. revenue. The post Pfizer Reaches Deal on Most-Favored Nation Drug Pricing;…
issue brief provides an overview of actions by the Trump administration and Congress that are likely to affect lawfully present immigrants’ access to health coverage and care, including new restrictions on eligibility for coverage and services as well as changes in immigration enforcement and other policies.
AbbVie schizophrenia drug candidate emraclidine failed to beat a placebo in two Phase 2 clinical trials. The drug, once projected to compete with Bristol Myers Squibb’s Cobenfy, is from AbbVie’s $8.7 billion acquisition of Cerevel Therapeutics. The post AbbVie Drug Expected to Rival Bristol Myers’s New Schizophrenia Med Flunks Phase 2 Test appeared first on…
Joining Matthew Holt (@boltyboy) on #THCBGang on Thursday December 5 at 1pm PST 4pm EST are patient safety expert Michael Millenson, patient advocate & entrepreneur Robin Farmanfarmaian; futurist Jeff Goldsmith; and employer & care consultant Brian Klepper. You can see the video below live (and later archived) & if you’d rather listen than watch, the audio…
We’d like to know what we can do to deliver more for our readers. The post Take Part in MedCity’s Audience Survey! appeared first on MedCity News.
Our annual family vacation on Cape Cod included all the familiar summer pleasures: climbing dunes, walking beaches, spotting seals, eating oysters, reading books we had intended to get to all year. And a little shopping. My grandkid wanted a few small toys. My daughter stocked up on thousand-piece jigsaw puzzles at the game store in…
Through a new partnership, Serve You Rx is leveraging Waltz Health’s AI-powered specialty pharmacy platform. The post Serve You Rx Teams Up with Waltz Health to Advance Specialty Pharmacy appeared first on MedCity News.
By VINCE KURAITIS & NEIL JENNINGS In a previous post in this series, we discussed healthcare’s migration toward Unified Digital Health Platforms (UDHPs) — a “platform of platforms.” Think of a UDHP as healthcare’s version of a Swiss Army knife: flexible, multi-functional, and (ideally) much better integrated than the drawer full of barely-used apps most health…
Eli Lilly drug Ebglyss is now FDA-approved for atopic dermatitis, an inflammatory skin disorder also known as eczema. The biologic drug came from Lilly’s $1.1 billion acquisition of Dermira in 2020. The post New Eli Lilly Eczema Drug Brings Competition and Dosing Edge Versus Sanofi, LEO Pharma Meds appeared first on MedCity News.
How has President Trump’s recent executive orders reshaped the US healthcare system? Below, I summarize the healthcare-related Executive Orders that were released this week: ACA premium subsidies will be reduced: Trump rescinded Biden’s executive order that led to longer enrollment periods for Affordable Care Act plans in most states. In short, in 2021, temporary subsidies…